Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging

Journal of the American College of Cardiology

Volumn 30, Issue 7, 1997, Pages 1687-1692

  Smanio, Paola E P ^a,b   Watson, Denny D ^a   Segalla, Dana L ^a   Vinson, Ellen L ^a   Smith, William H ^a   Beller, George A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CORONARY DISEASE; DIPYRIDAMOLE; DOBUTAMINE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031539281     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00363-X     Document Type: Article

References (35)

1. Mazullo P, Marcassa C, Sambuceti G, Parodi O, L'Abbate A. The clinical usefulness of electrocardiogram-gated Tc-99m methoxy-isobutyl-isonitrile images in the detection of basal wall motion abnormalities and reversibility of stress induced perfusion defects. Int J Card Imaging. 8:1992;131-141.
2. Marcassa C, Marzullo P, Parodi O, Sambuceti G, L'Abbate A. A new method for noninvasive quantitation of segmental myocardial wall thickening using technetium-99m 2-methoxy-isobutyl-isonitrile scintigraphy - results in normal subjects. J Nucl Med. 31:1990;173-177.
3. Villanueva-Meyer J, Mena I, Narahara KA. Simultaneous assessment of left ventricular wall motion and myocardial perfusion with technetium-99m-methoxy isobutyl isonitrile at stress and rest in patients with angina comparison with thallium-201 SPECT . J Nucl Med. 31:1990;457-463.
4. Najm YC, Timmis AD, Maisey MN, et al. The evaluation of ventricular function using gated myocardial imaging with Tc-99m MIBI. Eur Heart J. 10:1989;142-148.
5. Mannting F, Morgan-Mannting MG. Gated SPECT with technetium-99m-sestamibi for assessment of myocardial perfusion abnormalities. J Nucl Med. 34:1993;601-608.
6. Chua T, Kiat H, Germano G, et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability correlation with echocardiography and rest thallium-201 scintigraphy . J Am Coll Cardiol. 23:1994;1107-1114.
7. Tischler MD, Niggel JB, Battle RW, Fairbank JT, Brown KA. Validation of global and segmental left ventricular contractile function using gated planar technetium-99m sestamibi myocardial perfusion imaging. J Am Coll Cardiol. 23:1994;141-145.
8. Nicolai E, Cuocolo A, Pace L, et al. Assessment of systolic wall thickening using technetium-99m methoxyisobutylisonitrile in patients with coronary artery disease relation to thallium-201 scintigraphy with re-injection . Eur J Nucl Med. 22:1995;1017-1022.
9. Mazzanti M, Germano G, Kiat H, Friedman J, Berman DS. Fast technetium 99m-labeled sestamibi gated single-photon emission computed tomography for evaluation of myocardial function. J Nucl Cardiol. 3:1996;143-149.
10. Christian TF, O'Connor MK, Glynn RB, Rogers PJ, Gibbons RJ. The influence of gating on measurements of myocardium at risk and infarct size during acute myocardial infarction by tomographic technetium 99m-labeled sestamibi imaging. J Nucl Cardiol. 2:1995;207-216.
11. Berman DS, Germano G, Kiat H, Friedman J. Simultaneous perfusion/function imaging [editorial]. J Nucl Cardiol. 2:1995;271-273.
12. DePuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med. 36:1995;952-955.
13. Williams KA, Taillon LA. Reversible ischemia in severe stress technetium 99m-labeled sestamibi perfusion defects assessed from gated single-photon emission computed tomographic polar map Fourier analysis. J Nucl Cardiol. 2:1995;199-206.
14. DePuey EG, Nichols K, Dobrinsky C. Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT. J Nucl Med. 34:1993;1871-1876.
15. Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 36:1995;2138-2147.
16. Williams KA, Taillon LA. Left ventricular function in patients with coronary artery disease assessed by gated tomographic myocardial perfusion images comparison with assessment by contrast ventriculography and first-pass radionuclide angiography . J Am Coll Cardiol. 27:1996;173-181.
17. Boonyaprapa S, Ekmahachai M, Thanachaikun N, Jaiprasert W, Sukthomya V, Poramatikul N. Measurement of left ventricular ejection fraction from gated technetium-99m sestamibi myocardial images. Eur J Nucl Med. 22:1995;528-531.
18. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med. 300:1979;1350-1358.
19. Smith WH, Kastner RJ, Calnon DA, Segalla D, Beller GA, Watson DD. Quantitative gated SPECT imaging: a counts-based method for display and measurement of regional and global ventricular systolic function. J Nucl Cardiol. In press.
20. Calnon DA, Kastner RJ, Smith WH, Segalla D, Beller GA, Watson DD. Validation of a counts-based method for quantitating left ventricular systolic function using gated tomographic technetium-99m sestamibi perfusion images: comparison to equilibrium radionuclide angiography. J Nucl Cardiol. In press.
21. Beller GA. Clinical Nuclear Cardiology. 1995;82-136 WB Saunders, Philadelphia.
22. Berman DS, Kiat HS, Van Train KF, Germano G, Maddahi J, Friedman JD. Myocardial perfusion imaging with technetium-99m-sestamibi comparative analysis of available imaging protocols . J Nucl Med. 35:1994;681-688.
23. Watson DD, Smith WH, Beller GA, Vinson EL, Taillefer R. Blinded evaluation of planar technetium-99m-sestamibi myocardial perfusion studies. 1992;33:668-75.
24. Berman DS, Kiat H, Friedman JD, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography a clinical validation study . J Am Coll Cardiol. 22:1993;1455-1464.
25. Zaret BL, Wackers FJ. Nuclear cardiology [Part 1]. N Engl J Med. 329:1993;775-783.
26. Udelson JE. Choosing a thallium-201 or technetium 99m sestamibi imaging protocol. J Nucl Cardiol. 1:1994;S99-S108.
27. Van Train KF, Garcia EV, Maddahi J, et al. Multicenter trial validation for quantitative analysis of same-day rest-stress technetium-99m-sestamibi myocardial tomograms. J Nucl Med. 35:1994;609-618.
28. Stratmann HG, Williams GA, Wittry MD, Chaitman BR, Miller DD. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation. 89:1994;615-622.
29. Brown KA, Altland E, Rowen M. Prognostic value of normal technetium-99m sestamibi cardiac imaging. J Nucl Med. 35:1994;554-557.
30. Raiker K, Sinusas AJ, Wackers FJ, Zaret BL. One-year prognosis of patients with normal planar or single-photon emission computed tomographic technetium-99m-labeled sestamibi exercise imaging. J Nucl Cardiol. 1:1994;449-456.
31. Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography . J Am Coll Cardiol. 26:1995;639-647.
32. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease incremental prognostic value and use in risk stratification . Circulation. 93:1996;905-914.
33. Hachamovitch R, Berman DS, Kiat H, et al. Effective risk stratification using exercise myocardial perfusion SPECT in women gender-related differences in prognostic nuclear testing . J Am Coll Cardiol. 28:1996;34-44.
34. Boyne TS, Koplan BA, Parsons WJ, Smith WH, Watson DD, Beller GA. Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected or known coronary artery disease. Am J Cardiol. 79:1997;270-274.
35. Geleijnse ML, Elhendy A, van Domburg RT, et al. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol. 28:1996;447-454.